Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics.
Papaluca T, Roberts SK, Strasser SI, Stuart KA, Farrell G, MacQuillan G, Dore GJ, Wade AJ, George J, Hazeldine S, O'Beirne J, Wigg A, Fisher L, McGarity B, Sawhney R, Sinclair M, Thomas J, Valiozis I, Weltman M, Wilson M, Woodward A, Ahlenstiel G, Haque M
(2021), Clin Infect Dis, 73(9), e3295
DOI: 10.1093/cid/ciaa1318
Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia.
Lubel JS, Roberts SK, Howell J, Ward J, Shackel NA
(2021), Intern Med J, 51(2), 181-8
DOI: 10.1111/imj.15184
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
Vasudevan, Abhinav; Parthasarathy, Nina; Con, Danny; Nicolaides, Steven; Apostolov, Ross; Chauhan, Ayushi; Bishara, Maria; Luber, Raphael P.; Joshi, Neetima; Wan, Anna; Rickard, James A.; Long, Tony; Connoley, Declan; Sparrow, Miles P.; Gibson, Peter R.;
(2020), ALIMENT PHARM THER, 52(7), 1174-1184
DOI: 10.1111/apt.16039
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response
Sparrow, Miles P.; Papamichael, Konstantinos; Ward, Mark G.; Riviere, Pauline; Laharie, David; Paul, Stephane; Roblin, Xavier
(2020), J CROHNS COLITIS, 14(4), 542-556.
Editorial: balancing safety and efficacy-6-TGN thresholds in NUDT15 intermediate metabolisers treated with thiopurines
Digby-Bell, Jonathan; Ward, Mark G.
(2020), ALIMENT PHARM THER, 52(3), 554-555.
DOI: 10.1111/apt.15922
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases
Levine, Arie; Rhodes, Jonathan M.; Lindsay, James O.; Abreu, Maria T.; Kamm, Michael A.; Gibson, Peter R.; Gasche, Christoph; Silverberg, Mark S.; Mahadevan, Uma; Boneh, Rotem Sigall; Wine, Eyton; Damas, Oriana M.; Syme, Graeme; Trakman, Gina L.; Yao, Chu
(2020), CLIN GASTROENTEROL H, 18(6), 1381-1392.
Chronic constipation and abdominal pain: Independent or closely interrelated symptoms?
Wong, May Y.W.; Hebbard, Geoffrey; Gibson, Peter R.; Burgell, Rebecca E.
(2020), J GASTROEN HEPATOL, 35(8), 1294-1301
DOI: 10.1111/jgh.14970
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease
Julsgaard, Mette; Hvas, Christian L.; Gearry, Richard B.; Gibson, Peter R.; Fallingborg, Jan; Sparrow, Miles P.; Bibby, Bo M.; Connell, William R.; Brown, Steven J.; Kamm, Michael A.; Lawrance, Ian C.; Vestergaard, Thea; Svenningsen, Lise; Baekdal, Mille;
(2020), INFLAMM BOWEL DIS, 26(1), 93-102.
DOI: 10.1093/ibd/izz110
Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort
Con, Danny; Buckle, Andrew; Nicoll, Amanda J.; Lubel, John S.
(2020), JGH Open, 4(2), 106-112.
DOI: 10.1002/jgh3.12224
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn’s disease
Srinivasan, Ashish; van Langenberg, Daniel R.; Little, Robert D.; Sparrow, Miles P.; De Cruz, Peter; Ward, Mark G.
(2020), ALIMENT PHARM THER, 51(12), 1342-1352.
DOI: 10.1111/apt.15742
Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19
Prentice, Ralley E.; Tjandra, Doug; Garg, Mayur; Lubel, John S.; Fourlanos, Spiros; Johnson, Doug; Al-Ani, Aysha; Christensen, Britt
(2020), ALIMENT PHARM THER, 52(8), 1422-1423.
DOI: 10.1111/apt.16063
The authors reply
Majeed, Ammar; Majumdar, Avik; Bailey, Michael; Kemp, William; Bellomo, Rinaldo; Pilcher, David; Roberts, Stuart K.
(2020), CRIT CARE MED, 48(3), e258-e259.
Impact of 24-h high and low fermentable oligo-, di-, monosaccharide, and polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional heat stress
Gaskell, Stephanie K.; Taylor, Bonnie; Muir, Jane; Costa, Ricardo J.S.
(2020), APPL PHYSIOL NUTR ME, 45(6), 569-580.
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors
Garg, Mayur; Royce, Simon G.; Lubel, John S.
(2020), ALIMENT PHARM THER, 52(3), 569-570
DOI: 10.1111/apt.15814
The Potential of Integrated Nurse-Led Models to Improve Care for People With Functional Gastrointestinal Disorders
Linedale, Ecushla C.; Mikocka-Walus, Antonina; Gibson, Peter R.; Andrews, Jane M.
(2020), Gastroenterology Nursing, 43(1), 53-64.
The international anorectal physiology working group (IAPWG) recommendations
Carrington, Emma V.; Heinrich, Henriette; Knowles, Charles H.; Fox, Mark; Rao, Satish; Altomare, Donato F.; Bharucha, Adil E.; Burgell, Rebecca; Chey, William D.; Chiarioni, Guiseppe; Dinning, Philip; Emmanuel, Anton; Farouk, Ridzuan; Felt-Bersma, Richell
(2020), NEUROGASTROENT MOTIL, 32(1), e13679
DOI: 10.1111/nmo.13679
The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis
Ardalan, Zaid S.; Sparrow, Miles; Gibson, Peter R.
(2020), GASTROENTEROLOGY, 159(1), 359-400.
Systematic Review: Clinical Utility of Gastrointestinal Ultrasound in the Diagnosis, Assessment and Management of Patients With Ulcerative Colitis
Smith, Rebecca L.; Taylor, Kirstin M.; Friedman, Antony B.; Gibson, Robert N.; Gibson, Peter R.
(2020), J CROHNS COLITIS, 14(4), 465-479.
Survival of patients with ruptured and non-ruptured hepatocellular carcinoma
Tan, Natassia P.; Majeed, Ammar; Roberts, Stuart K.; Gow, Paul J.; Hey, Penny; Mah, Xianjun; Goodwin, Mark; Sood, Siddharth; Lubel, John; Nicoll, Amanda; Dev, Anouk; Bell, Sally J.; Kemp, William W.
(2020), MED J AUSTRALIA, 212(6), 277-278.
DOI: 10.5694/mja2.50483